Effectiveness of bivalent and quadrivalent human papillomavirus vaccination in Luxembourg

Background: In Luxembourg, the human papillomavirus (HPV) vaccination program introduced in 2008, provided either bivalent (BV) or quadrivalent (QV) vaccines to girls aged 12-17 years. Here, we estimate the effectiveness of BV and QV vaccines combined and separately in reducing type-specific HPV pre...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Latsuzbaia, Ardashel, Arbyn, Marc, Tapp, Jessica, Fischer, Marc, Weyers, Steven, Pesch, Pascale, Mossong, Joel
Format:	Artikel
Sprache:	eng
Schlagworte:	Bivalent vaccine Cervical cancer effectiveness GENITAL WARTS HERD-IMMUNITY HPV HPV vaccine Human papillomavirus IMPACT Luxembourg Medicine and Health Sciences PHASE prevalence Quadrivalent vaccine REPLACEMENT Vaccine WOMEN
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!